Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04752891
Other study ID # 20-HPNCL-07
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 10, 2021
Est. completion date March 16, 2023

Study information

Verified date March 2023
Source Fondation Lenval
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Otitis media (OM) is one of the most common childhood infections and is a major cause of morbidity in children and results as being the first cause of antibiotic prescription among children in developed countries . An artificial intelligence-based tool could help physicians refine their diagnosis


Description:

Ear infections in children are very common, particularly acute otitis media (AOM) which represents the first reason for visiting physicians and for antibiotic prescription in children in developed countries. However, the diagnosis is not easy because of the narrowness of the ear canal, the discomfort of the child during the otoscopic exam. Moreover, the accuracy of the AOM diagnosis depends on the subjectivity of the physician mostly. This can result in an misdiagnosis and inappropriate treatment with, as a result, the emergence of multi-resistant germ. Artificial intelligence (AI) in medicine is booming and has already proven its worth in terms of prevention, monitoring and diagnosis. I-Nside, an app based on Artificial Intelligence is able to make automatic diagnosis of many ear pathologies, after capturing picture of any eardrum using an otoendoscope fixed on a connected smartphone (SmartScope®). Therefore, the investigators aim to assess the accuracy of AOM diagnosis the existing app, by comparing the inter-rater agreement between the diagnosis made by a senior physician using a traditional otoscope (considered as "gold standard" ) and the one made by a junior physician using the app


Recruitment information / eligibility

Status Completed
Enrollment 203
Est. completion date March 16, 2023
Est. primary completion date August 16, 2022
Accepts healthy volunteers No
Gender All
Age group N/A to 17 Years
Eligibility Inclusion Criteria: Child under 18 years Presenting signs that may suggest acute otitis media (fever, earache, purulent otorrhea) For which the informed written consent of, at least, one of the two parents or the holder of parental authority has been obtained Exclusion Criteria: A sign (s) of vital distress Trans-tympanic drains -

Study Design


Related Conditions & MeSH terms


Intervention

Other:
AOM diagnosis with app
the diagnosis made by a senior physician using a traditional otoscope. the diagnosis made by the junior physician using an otoendoscope fixed on a connected smartphone
AOM diagnosis without app
the diagnosis made by a senior physician and by the junior physician, using a traditional otoscope

Locations

Country Name City State
France Hôpitaux Pédiatrique de Nice CHU Lenval Nice

Sponsors (1)

Lead Sponsor Collaborator
Fondation Lenval

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary diagnosis of purulent Acute Otitis Media (AOM) made by junior physicians using the i-Nside application associated with Smartscope® diagnosis of purulent AOM is made on an inflammatory aspect of the eardrum with retrotympanic effusion, exteriorized (otorrhea) or not (opacity, effacement of reliefs or bulging, disappearance of the light triangle). at inclusion
Primary diagnosis of purulent Acute Otitis Media (AOM) made by senior physicians using a standard otoscope diagnosis of purulent AOM is made on an inflammatory aspect of the eardrum with retrotympanic effusion, exteriorized (otorrhea) or not (opacity, effacement of reliefs or bulging, disappearance of the light triangle) at inclusion
Secondary rate of misdiagnoses of purulent Acute Otitis Media (AOM) with and without the use of the application a misdiagnosis is measured by a discordant diagnosis of the juniors compared to the seniors considered as the Gold Standard for the AOM diagnosis at inclusion
Secondary collection risk factors for a discrepancy in the diagnosis of purulent AOM collection data of age of patients,pain requiring analgesia, period of the day of diagnosis (morning, afternoon,night) at inclusion
Secondary satisfaction of junior physicians regarding the use of the app a questionnaire will be given at the end of the study. The questions relate to the use of the application and its perceived usefulness by practitioners. Satisfaction will be assessed by a Lickert scale through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Completed NCT01244581 - Amoxicillin-clavulanate in Treating Acute Otitis Media Evaluated by Daily Tympanometry Phase 3
Completed NCT05605262 - Effects of 100% Medical Grade Manuka Honey on Tympanic Membrane Reconstruction Healing. Phase 2/Phase 3
Terminated NCT00315003 - TELI COM - Telithromycin in Children With Otitis Media Phase 3